explore -WSS

explore

author：entertainment 2025-10-01 22:58:33 - browse：2

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Wikipedia

WSS

Hospitals consider fixing cancer drug shortages on their own

A biotech analyst on neuroscience, placebo effect, not over

Will the IRA bring competition to the biologics market?

Anavex keeps shifting the goalposts in its clinical trials

Acelyrin, a rare IPO success, stumbles in its first big test

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Medicare details structure of new drug price negotiation program

In same hospitals, Black patients receive fewer opioids than white patients

Anesthesiologist group: stop taking Ozempic before surgery

IRA could hurt research into orphan drugs for rare diseases

State Dept. review finds Biden bears some blame for Afghanistan failures

How housing is health care on Long Island

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

American woman, child freed after being kidnapped in Haiti last month

Apple is now the first public company to be valued at $3 trillion

What to make of Biden’s latest efforts on cancer research

hotspot

In same hospitals, Black patients receive fewer opioids than white patients

Friends ask where James Watson's attitudes about race came from

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Telehealth for opioid use disorder is lifesaving

NIH trials fail to test meaningful long Covid therapies, experts say

New Covid vaccine is recommended for everyone 6 months or older

focus

Wikipedia

explore

knowledge